BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36318825)

  • 21. MiR-455-5p upregulation in umbilical cord mesenchymal stem cells attenuates endometrial injury and promotes repair of damaged endometrium via Janus kinase/signal transducer and activator of transcription 3 signaling.
    Sun D; Jiang Z; Chen Y; Shang D; Miao P; Gao J
    Bioengineered; 2021 Dec; 12(2):12891-12904. PubMed ID: 34784837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.
    Yue P; Zhang X; Paladino D; Sengupta B; Ahmad S; Holloway RW; Ingersoll SB; Turkson J
    Oncogene; 2012 May; 31(18):2309-22. PubMed ID: 21909139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy.
    Shu B; Zhou Y; Liang Q; He C; Li F
    Exp Mol Pathol; 2021 Dec; 123():104691. PubMed ID: 34606781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat Shock Protein 27 Enhances SUMOylation of Heat Shock Protein B8 to Accelerate the Progression of Breast Cancer.
    Wang S; Zhang X; Wang H; Wang Y; Chen P; Wang L
    Am J Pathol; 2020 Dec; 190(12):2464-2477. PubMed ID: 33222991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway.
    Luo XY; Liu Q; Yang H; Tan Q; Gan LQ; Ren FL; Wang H
    Mol Med; 2018 Jun; 24(1):28. PubMed ID: 30134804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing of
    Zhang P; Li Z; Yang G
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
    Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
    Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of LINC01322 as a potential prognostic biomarker and oncogene promoting tumor progression in lung adenocarcinoma.
    Zeng L; Mi K; Peng L; Wen H; Jiao T; Lyu X; Jiao T; Chen Y; Yuan J; Zhang L; Yang S
    Int J Biochem Cell Biol; 2024 Apr; 169():106552. PubMed ID: 38403048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.
    Liu L; Nam S; Tian Y; Yang F; Wu J; Wang Y; Scuto A; Polychronopoulos P; Magiatis P; Skaltsounis L; Jove R
    Cancer Res; 2011 Jun; 71(11):3972-9. PubMed ID: 21610112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eukaryotic Elongation Factor 1Alpha-2 (EEF1A2) Participates in the Progression of Gastric Cancer via Interaction with Heat Shock Protein B8 (HSPB8).
    Li J; Tang X; Zhang Z
    Ann Clin Lab Sci; 2023 May; 53(3):398-408. PubMed ID: 37437931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dieckol prevents prostate cancer cell proliferation by transcriptionally attenuating JAK/STAT3 signaling pathway.
    Karuppaiya V; Annamalai A; Krishnamurthy S; Soundarapandian K
    Environ Toxicol; 2024 Mar; 39(3):1187-1196. PubMed ID: 37886886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esculetin Inhibits Proliferation, Invasion, and Migration of Laryngeal Cancer In Vitro and In Vivo by Inhibiting Janus Kinas (JAK)-Signal Transducer and Activator of Transcription-3 (STAT3) Activation.
    Zhang G; Xu Y; Zhou HF
    Med Sci Monit; 2019 Oct; 25():7853-7863. PubMed ID: 31630150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diallyl trisulfide inhibits activation of signal transducer and activator of transcription 3 in prostate cancer cells in culture and in vivo.
    Chandra-Kuntal K; Singh SV
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1473-83. PubMed ID: 20959517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
    Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J
    Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK/STAT signaling pathway.
    Song X; Ma J
    Tissue Cell; 2022 Dec; 79():101954. PubMed ID: 36270072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway.
    Khan AQ; Ahmed EI; Elareer N; Fathima H; Prabhu KS; Siveen KS; Kulinski M; Azizi F; Dermime S; Ahmad A; Steinhoff M; Uddin S
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
    Sen B; Saigal B; Parikh N; Gallick G; Johnson FM
    Cancer Res; 2009 Mar; 69(5):1958-65. PubMed ID: 19223541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HSPB8 promotes cancer cell growth by activating the ERK‑CREB pathway and is indicative of a poor prognosis in gastric cancer patients.
    Shen J; Li M; Min L
    Oncol Rep; 2018 Jun; 39(6):2978-2986. PubMed ID: 29693129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells.
    Piccolella M; Crippa V; Cristofani R; Rusmini P; Galbiati M; Cicardi ME; Meroni M; Ferri N; Morelli FF; Carra S; Messi E; Poletti A
    Oncotarget; 2017 Feb; 8(6):10400-10415. PubMed ID: 28060751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.